Skip to main content
Clinical Trials/ACTRN12619000960156
ACTRN12619000960156
Completed
未知

Assessment of a New Novel Fluid Monitoring Device in Heart Failure Patients

Safehouse Innovation Ltd0 sites20 target enrollmentJuly 8, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Congestive heart failure (CHF)
Sponsor
Safehouse Innovation Ltd
Enrollment
20
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 8, 2019
End Date
January 24, 2020
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Safehouse Innovation Ltd

Eligibility Criteria

Inclusion Criteria

  • Male and female Age 18 years\+
  • Heart failure Condition
  • Hospitalised with significant fluid overload for fluid offload.
  • Ability to give written informed consent and agree to adhere to all protocol requirements.

Exclusion Criteria

  • Patient has been prescribed to wear TED stockings throughout the duration of their hospital stay.
  • Leg prosthesis or other disorders making measurement of leg oedema difficult or inadvisable.

Outcomes

Primary Outcomes

Not specified

Similar Trials